selected scholarly activity
-
conferences
- A Phase 3, Multicenter, Randomized Trial to Evaluate the Symptomatic and Quality of Life Improvements in Lung Cancer Patients Receiving External Beam Radiation With or Without High Dose Rate Intraluminal Brachytherapy. International Journal of Radiation Oncology Biology Physics. S116-S116. 2017
- Early Outcomes of Patients With Locally Advanced Esophageal Cancer Treated With Trimodality Treatments. International Journal of Radiation Oncology Biology Physics. E175-E175. 2017
- Brachytherapy for Endobronchial Metastasis: An Effective Method of Achieving Palliative Relief of Symptoms. International Journal of Radiation Oncology Biology Physics. E439-E440. 2016
- High Dose Rate Brachytherapy: An Effective Treatment for Lower Gastrointestinal Malignancies. International Journal of Radiation Oncology Biology Physics. E170-E170. 2015
- Intraluminal Brachytherapy: An Effective Palliation for Cholangiocarcinoma Causing Bile Duct Obstruction?. International Journal of Radiation Oncology Biology Physics. E129-E129. 2015
- Photodynamic Therapy (PDT) With Porfimer Sodium Sensitizer Using HDR Planning Principles: A Single-Institution Experience of an Alternative Cancer Treatment. International Journal of Radiation Oncology Biology Physics. E476-E477. 2015
- A Prospective Comparative Analysis of 3 Methods of Rectal Retraction for High-Dose-Rate Brachytherapy in Cervical Carcinoma: Effect on Organs at Risk. International Journal of Radiation Oncology Biology Physics. S476-S477. 2014
- Tracheal Tumors Treated With Endotracheal Brachytherapy Alone: Experience From a Single Institution. International Journal of Radiation Oncology Biology Physics. S663-S663. 2014
- Results of a Prospective Study on Brachytherapy in Lung Cancer in Combination with other Modalities. International Journal of Radiation Oncology Biology Physics. S440-S441. 2008
- Value of Chemotherapy with ECF in Advanced Esophageal Cancer Treated with Endoscopic Guided High Dose Rate Intraluminal Brachytherapy (EGHDRILBT). International Journal of Radiation Oncology Biology Physics. S267-S267. 2008
- Does the Addition of External Beam to HDR Intraluminal Brachytherapy, Improve Palliation of Esophageal Cancer: A Randomized International Multi-institutional Trial. International Journal of Radiation Oncology Biology Physics. S107-S107. 2007
- Endoscopic-Guided Brachytherapy (EGB) for the palliation of advanced esophageal cancers. Radiotherapy and Oncology. S67-S68. 2007
- High dose rate intraluminal Brachytherapy (HDRILBT) in lung cancer: A review of two years. Radiotherapy and Oncology. S56-S57. 2007
- The value of CT Imaging for treatment planning for brachytherapy in lung cancer. Radiotherapy and Oncology. S59-S59. 2007
- Worklife in Brachytherapy. Radiotherapy and Oncology. S68-S68. 2007
- 3503 ORAL Adding external beam to HDR-intraluminal brachytherapy, improves palliation of oesophageal cancer: a prospective randomized, multicentre trial of the International Atomic Energy Agency. European Journal of Cancer, Supplement. 260-260. 2007
- Phase II pilot study on brachytherapy with ECF vs brachytherapy and standard chemoradiation in esophageal cancer. Annals of Oncology. VII90-VII91. 2007
- 2177. International Journal of Radiation Oncology Biology Physics. S308-S308. 2006
- Cetuximab improves locoregional control and survival of locoregionally advanced head and neck cancer: Independent review of mature data with a median follow-up of 45 months.. Clinical Cancer Research. 9058S-9058S. 2005
- P-126 Activation of tyrosine kinase receptors and intracellular signal mediators in NSCLC tumors. Lung Cancer. S148-S148. 2005
- Malignant thymoma: A review of treatment experience from two Canadian institutions.. Radiotherapy and Oncology. S38-S38. 2004
- Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone. International Journal of Radiation Oncology Biology Physics. S205-S205. 2004
- Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone. Radiotherapy and Oncology. S17-S18. 2004
- The spectrum of HIV-1 related cancers in South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). A15-A15. 2000
- Palliative treatment of oesophageal carcinoma combining brachytherapy and recurrent dilatation using the Didcott Dilator (D/D). INTERNATIONAL CONGRESS OF THORAX SURGERY. 305-310. 1997
-
journal articles
- Endobronchial brachytherapy for metastasis from extrapulmonary malignancies as an effective treatment for palliation of symptoms. Brachytherapy. 16:630-638. 2017
- Low-dose non-targeted radiation effects in human esophageal adenocarcinoma cell lines. International Journal of Radiation Biology. 93:165-173. 2017
- Prospective comparison of rectal dose reduction during intracavitary brachytherapy for cervical cancer using three rectal retraction techniques. Brachytherapy. 15:450-455. 2016
- The influence of smoking on radiation-induced bystander signal production in esophageal cancer patients. Environmental Research. 147:565-571. 2016
- A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 17:142-149. 2016
- Assessing patient characteristics and radiation-induced non-targeted effects in vivo for high dose-rate (HDR) brachytherapy. International Journal of Radiation Biology. 91:786-794. 2015
- A prospective analysis of high-dose-rate endobronchial brachytherapy in the palliation of obstructive symptoms in lung cancer patients: A single-institution experience. Brachytherapy. 14:655-661. 2015
- Brachytherapy in lung cancer: a review. Translational Cancer Research. 4:381-396. 2015
- Endotracheal brachytherapy alone: An effective palliative treatment for tracheal tumors. Brachytherapy. 14:543-548. 2015
- Surface mold brachytherapy for nonmelanoma skin cancer: Canadian patterns of practice. Practical Radiation Oncology. 4:398-403. 2014
- 2D/3D registration algorithm for lung brachytherapy. Medical Physics. 40:021913-021913. 2013
- The involvement of serum serotonin levels producing radiation-induced bystander effects for an in vivo assay with fractionated high dose-rate (HDR) brachytherapy. International Journal of Radiation Biology. 88:791-797. 2012
- Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline. Practical Radiation Oncology. 1:60-71. 2011
- Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: A prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiotherapy and Oncology. 97:488-494. 2010
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. The Lancet Oncology. 11:21-28. 2010
- Endoscopic brachytherapy for obstructive colorectal cancer. Brachytherapy. 8:313-317. 2009
- Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non–Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial. International Journal of Radiation Oncology Biology Physics. 73:1069-1076. 2009
- In Vitro Survival of Nonsmall Cell Lung Cancer Cells Following Combined Treatment with Ionizing Radiation and Photofrin‐mediated Photodynamic Therapy. Photochemistry and Photobiology. 85:99-106. 2009
- Haemoglobin level as the prognostic factor for patients with carcinoma of the cervix receiving radiation therapy. South African Journal of Obstetrics and Gynaecology. 14:76-80. 2008
- Association of Phosphorylated Epidermal Growth Factor Receptor with Survival in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Radiotherapy. Journal of Thoracic Oncology. 3:716-722. 2008
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck. New England Journal of Medicine. 354:567-578. 2006
- Low socioeconomic status and risk for infection with Human Herpesvirus 8 among HIV-1 negative, South African black cancer patients. Epidemiology and Infection. 132:1191-1197. 2004
- Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer. Brachytherapy. 3:191-195. 2004
- Risk factors for high anti-HHV-8 antibody titers (≥1:51,200) in black, HIV-1 negative South African cancer patients: a case control study. BMC Infectious Diseases. 3:21. 2003
- In response to Dr. Shakespeare. International Journal of Radiation Oncology Biology Physics. 55:850-850. 2003
- Gastrointestinal stromal tumours of the oesophagus.. South African Journal of Surgery. 41:21-23. 2003
- Preliminary report on the effect of brachytherapy on expression of p53, bc1-2 and apoptosis in squamous cell carcinoma of the oesophagus.. South African Journal of Surgery. 41:14-20. 2003
- Recommendations for implementation of high dose rate 192Ir brachytherapy in developing countries by the Advisory Group of International Atomic Energy Agency. Radiotherapy and Oncology. 64:297-308. 2002
- External Beam Radiotherapy: A Treatment Option for Massive Haemoptysis Caused by Mycetoma. Clinical Oncology. 14:233-235. 2002
- Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans. British Journal of Cancer. 86:1751-1756. 2002
- The spectrum of HIV-1 related cancers in South Africa. International Journal of Cancer. 88:489-492. 2000
- Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.. Journal of Clinical Pathology - Clinical Molecular Pathology. 50:534-534. 1997
- Symmetrical multifocal liposarcoma.. South African Journal of Surgery. 35:68-69. 1997
- Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy. Cancer. 77:2200-2205. 1996